Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,178 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world data on treatment patterns and outcomes of hypomethylating therapy in patients with newly diagnosed acute myeloid leukaemia aged ≥ 60 years.
Österroos A, Eriksson A, Antunovic P, Cammenga J, Deneberg S, Lazarevic V, Lorenz F, Möllgård L, Derolf ÅR, Uggla B, Wennström L, Ölander E, Höglund M, Juliusson G, Lehmann S. Österroos A, et al. Among authors: lehmann s. Br J Haematol. 2020 Apr;189(1):e13-e16. doi: 10.1111/bjh.16410. Epub 2020 Feb 26. Br J Haematol. 2020. PMID: 32103493 Free article. No abstract available.
Challenging conventional karyotyping by next-generation karyotyping in 281 intensively treated patients with AML.
Mareschal S, Palau A, Lindberg J, Ruminy P, Nilsson C, Bengtzén S, Engvall M, Eriksson A, Neddermeyer A, Marchand V, Jansson M, Björklund M, Jardin F, Rantalainen M, Lennartsson A, Cavelier L, Grönberg H, Lehmann S. Mareschal S, et al. Among authors: lehmann s. Blood Adv. 2021 Feb 23;5(4):1003-1016. doi: 10.1182/bloodadvances.2020002517. Blood Adv. 2021. PMID: 33591326 Free PMC article.
Biological and therapeutic implications of a unique subtype of NPM1 mutated AML.
Mer AS, Heath EM, Madani Tonekaboni SA, Dogan-Artun N, Nair SK, Murison A, Garcia-Prat L, Shlush L, Hurren R, Voisin V, Bader GD, Nislow C, Rantalainen M, Lehmann S, Gower M, Guidos CJ, Lupien M, Dick JE, Minden MD, Schimmer AD, Haibe-Kains B. Mer AS, et al. Among authors: lehmann s. Nat Commun. 2021 Feb 16;12(1):1054. doi: 10.1038/s41467-021-21233-0. Nat Commun. 2021. PMID: 33594052 Free PMC article.
A risk score based on real-world data to predict early death in acute promyelocytic leukemia.
Österroos A, Maia T, Eriksson A, Jädersten M, Lazarevic V, Wennström L, Antunovic P, Cammenga J, Deneberg S, Lorenz F, Möllgård L, Uggla B, Ölander E, Aguiar E, Trigo F, Höglund M, Juliusson G, Lehmann S. Österroos A, et al. Among authors: lehmann s. Haematologica. 2022 Jul 1;107(7):1528-1537. doi: 10.3324/haematol.2021.280093. Haematologica. 2022. PMID: 35081688 Free PMC article.
Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications.
Nilsson C, Linde F, Hulegårdh E, Garelius H, Lazarevic V, Antunovic P, Cammenga J, Deneberg S, Eriksson A, Jädersten M, Björkvall CK, Möllgård L, Wennström L, Ölander E, Höglund M, Juliusson G, Lehmann S. Nilsson C, et al. Among authors: lehmann s. Haematologica. 2023 Apr 1;108(4):1015-1025. doi: 10.3324/haematol.2022.281233. Haematologica. 2023. PMID: 36005563 Free PMC article.
Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies.
Herold N, Rudd SG, Ljungblad L, Sanjiv K, Myrberg IH, Paulin CB, Heshmati Y, Hagenkort A, Kutzner J, Page BD, Calderón-Montaño JM, Loseva O, Jemth AS, Bulli L, Axelsson H, Tesi B, Valerie NC, Höglund A, Bladh J, Wiita E, Sundin M, Uhlin M, Rassidakis G, Heyman M, Tamm KP, Warpman-Berglund U, Walfridsson J, Lehmann S, Grandér D, Lundbäck T, Kogner P, Henter JI, Helleday T, Schaller T. Herold N, et al. Among authors: lehmann s. Nat Med. 2017 Feb;23(2):256-263. doi: 10.1038/nm.4265. Epub 2017 Jan 9. Nat Med. 2017. PMID: 28067901
1,178 results